Study to assess the efficacy clinical trial and safety of intranasal administration of ethamsylate in the treatment of hereditary hemorrhagic telangiectasia, during 4 weeks
- Registry ID
- EUCTR2016-003982-24
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE4
- Sponsor
- Asociación HHT España
- Start date
- 2017-03-16
- Last update
- 2026-08-16
Conditions
- Hereditary hemorrhagic telangiectasia
Summary
To evaluate the efficacy of daily administration of intranasal Ethamsylate in improving the HHT at 4 weeks of starting treatment, by measuring the number of epistaxis per week and features.
Locations
View on source registry